HotSpotter: efficient visualization of driver mutations
Open Access
- 1 January 2014
- journal article
- research article
- Published by Springer Nature in BMC Genomics
- Vol. 15 (1) , 1044
Abstract
Driver mutations are positively selected during the evolution of cancers. The relative frequency of a particular mutation within a gene is typically used as a criterion for identifying a driver mutation. However, driver mutations may occur with relative infrequency at a particular site, but cluster within a region of the gene. When analyzing across different cancers, particular mutation sites or mutations within a particular region of the gene may be of relatively low frequency in some cancers, but still provide selective growth advantage. This paper presents a method that allows rapid and easy visualization of mutation data sets and identification of potential gene mutation hotspot sites and/or regions. As an example, we identified hotspot regions in the NFE2L2 gene that are potentially functionally relevant in endometrial cancer, but would be missed using other analyses. HotSpotter is a quick, easy-to-use visualization tool that delivers gene identities with associated mutation locations and frequencies overlaid upon a large cancer mutation reference set. This allows the user to identify potential driver mutations that are less frequent in a cancer or are localized in a hotspot region of relatively infrequent mutations.Keywords
This publication has 11 references indexed in Scilit:
- Mutational landscape and significance across 12 major cancer typesNature, 2013
- Identifying driver mutations from sequencing data of heterogeneous tumors in the era of personalized genome sequencingBriefings in Bioinformatics, 2013
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- The UCSC Cancer Genomics Browser: update 2013Nucleic Acids Research, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trialThe Lancet, 2012
- New Strategies in Melanoma: Molecular Testing in Advanced DiseaseClinical Cancer Research, 2012
- NFE2L2 Gene Mutation in Male Japanese Squamous Cell Carcinoma of the LungJournal of Thoracic Oncology, 2010
- The cancer genomeNature, 2009
- The COSMIC (Catalogue of Somatic Mutations in Cancer) database and websiteBritish Journal of Cancer, 2004